Our Commitment to Responsibility
At Bristol-Myers Squibb, we are firmly focused on our Mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. In addition, we are steadfast in our Commitment to economic, social and environmental sustainability.
Integrity is the foundation from which we operate. As a BioPharma leader, we take our responsibilities seriously, and always strive to do the right thing for the benefit of the patients we serve around the world, our company, our employees, our shareholders and our communities.
We know that all too often, patients worldwide face health disparities and barriers to health care. Certain populations – particularly the urban and rural poor, women, racial and ethnic minorities, and marginalized people – experience worse health outcomes compared with others. Through the Bristol-Myers Squibb Foundation, we seek to bridge gaps in health care in fighting HIV/AIDS in Africa, hepatitis in Asia, serious mental illness in the U.S., and cancer in central and eastern Europe. Most recently, we launched Together on Diabetes®, the largest corporate initiative in the U.S. to fight type 2 diabetes.
The model for these programs is Bristol-Myers Squibb’s groundbreaking SECURE THE FUTURE®. This $150 million program has funded more than 240 projects and now supports programs in 20 African countries, integrating clinic-based medical care with community-based health education and supportive care.
Through the Bristol-Myers Squibb Patient Assistance Foundation, we provide free medications to qualifying patients in the U.S. with financial hardship who generally have no private prescription drug insurance and are not enrolled in a prescription drug coverage plan through Medicaid or any other federal, state or local health program. In addition, the Bristol-Myers Squibb Foundation has provided funding support to international relief partners, to help enable timely responses with humanitarian aid to sudden natural disasters. It has also used its resources and relationships with international relief agencies to expand health care resources in developing countries.
Bristol-Myers Squibb strives to be a good neighbor, supporting the communities where we live and do business. We are particularly interested in helping to address unmet medical needs in the community through non-profit partners, improving science education and re-engaging students in local schools, and helping people in need through philanthropy and volunteerism.
Preservation of natural resources represents one of our key commitments. Our Sustainability 2010 Goals, initiated in 2000, have resulted in significant progress in reducing Bristol-Myers Squibb’s environmental impacts worldwide. Since then, the company has met and surpassed the majority of its goals, including a 40 percent reduction in energy use, normalized to sales. I am particularly proud of the Green Building Council’s LEED certification for our state-of-the-art biologics manufacturing facility in Devens, Massachusetts.
As Bristol-Myers Squibb focuses on the future, our next generation of sustainability goals (through 2015), intensifies our commitment to sustainable, ethical and compliant global business practices. We have a long history of public reporting that increases transparency and enhances public trust. Since helping to pilot the first Global Reporting Initiative guidelines, we have used these updates to guide our external reporting on bms.com. I invite you to track our progress against our commitments.
Our employees are the foundation of our success. At Bristol-Myers Squibb, we foster a diverse workforce and an inclusive culture, with the recognition that with diversity comes strength. Our Employee Resource Groups and employee development opportunities help create such a culture. Bristol-Myers Squibb has been recognized year after year as one of the best companies for female executives and working parents. We have also been recognized by the Human Rights Campaign Foundation’s Corporate Equality Index.
Global health care challenges are daunting. We recognize that as we provide innovative medicines for patients in need we must work together with governments, payers, patients, health care providers and other stakeholders to develop workable and sustainable solutions. As part of our Mission to help patients prevail, this is what we do.